Skip to main content
. 2023 Aug 24;26(3):257–269. doi: 10.1093/ntr/ntad156

Table 1.

Longitudinal Study Characteristics and Outcomes

Author year Total N Time CO for inclusion CPD at baseline % Change from baseline Risk of bias
Follow-up group N NNAL NNN NAB NAT<
RCT RoB2
Jay 202040* 90 5 days CO ≥12 ppm CPD M = 16.2 SD = 3.6 Vaping n = 60
Nonuse n = 11
↓68%
↓67%
↓61%
↓99%
Some concerns
Round 201939* 158 5 days CPD M = 14.4 Vaping+n = 38
Vaping+n = 40
↓59%
↓55%
↓87%
↓92%
Some concerns
Cohen 202137* 295 6 days CO >10 ppm CPD M = 18 SD = 5.2 Vaping n = 188
Nonuse n = 23
↓66%
↓64%
↓93%
↓97%
↓89%
↓87%
↓99%
↓98%
Some concerns
McEwan 202142* 148 7 days CO >10 ppm CPD M = 20.1 SD = 4.83 Vaping n = 28
Nonuse n = 29
↓65%
↓68%
↓77%
↓80%
Some concerns
Morris 202236* 80 14 days CO >10ppm CPD > 10 Vaping+n = 14
Vaping+n = 11
↓73%
↓79%
↓92%
↓89%
Some concerns
Pulvers 202041 186 6 weeks CO >5ppm CPD M = 12.1 SD = 7.2 Vaping n = 32 ↓95% Some concerns
Hatsukami 202038 264 8 weeks CO ≥8 ppm CPD > 5 Vaping n = 57 ↓53% Some concerns
Edmiston 202235* 150 24 weeks CPD M = 17.6 SD = 5.0 Vaping+n = 48
Vaping+n = 50
↓84%
↓73%
Some concerns
Non-randomized intervention study ROBINS-I
Goniewicz 201743 20 2 weeks CPD M = 16 SD = 9 Vaping n = 9 ↓72% Moderate
Pulvers 201844 40 4 weeks CPD M = 8.8 SD = 6.53 Vaping n = 6 ↓97% Moderate
Observational longitudinal Newcastle-Ottawa
Anic 202246 2475 12 months CPD M = 11
CPD M = 5
Vaping n = 28
Nonuse n = 188
↓93%
↓85%
↓83%
↓44%
↓89%
↓65%
↓94%
↓75%
7/9
Dai 202245 3211 12 months CPD M = 16.7 Vaping n = 32
Nonuse n = 246
↓92%
↓84%
↓82%
↓44%
↓90%
↓63%
↓96%
↓74%
7/9

+ Results were separated by vape flavor, see Supplementary Table S6 for details.

*Denotes studies funded by the tobacco industry.

CPD = cigarettes per day, CO = carbon monoxide, M = mean, SD = standardized deviation, ↓ indicates % decrease between baseline and follow-up.

Unless otherwise stated, results indicate urinary levels.